In vivo tumor growth of high-grade serous ovarian cancer cell lines

Anirban Mitra, David A. Davis, Sunil Tomar, Lynn Roy, Hilal Gurler, Jia Xie, Daniel D. Lantvit, Horacio Cardenas, Fang Fang, Yueying Liu, Elizabeth Loughran, Jing Yang, M. Sharon Stack, Robert Emerson, Karen Cowden Dahl, Maria V. Barbolina, Kenneth Nephew, Daniela Matei, Joanna E. Burdette

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Objective Genomic studies of ovarian cancer (OC) cell lines frequently used in research revealed that these cells do not fully represent high-grade serous ovarian cancer (HGSOC), the most common OC histologic type. However, OC lines that appear to genomically resemble HGSOC have not been extensively used and their growth characteristics in murine xenografts are essentially unknown. Methods To better understand growth patterns and characteristics of HGSOC cell lines in vivo, CAOV3, COV362, KURAMOCHI, NIH-OVCAR3, OVCAR4, OVCAR5, OVCAR8, OVSAHO, OVKATE, SNU119 and UWB1.289 cells were assessed for tumor formation in nude mice. Cells were injected intraperitoneally (i.p.) or subcutaneously (s.c.) in female athymic nude mice and allowed to grow (maximum of 90 days) and tumor formation was analyzed. All tumors were sectioned and assessed using H&E staining and immunohistochemistry for p53, PAX8 and WT1 expression. Results Six lines (OVCAR3, OVCAR4, OVCAR5, OVCAR8, CAOV3, and OVSAHO) formed i.p xenografts with HGSOC histology. OVKATE and COV362 formed s.c. tumors only. Rapid tumor formation was observed for OVCAR3, OVCAR5 and OVCAR8, but only OVCAR8 reliably formed ascites. Tumors derived from OVCAR3, OVCAR4, and OVKATE displayed papillary features. Of the 11 lines examined, three (Kuramochi, SNU119 and UWB1.289) were non-tumorigenic. Conclusions Our findings help further define which HGSOC cell models reliably generate tumors and/or ascites, critical information for preclinical drug development, validating in vitro findings, imaging and prevention studies by the OC research community.

Original languageEnglish
Pages (from-to)372-377
Number of pages6
JournalGynecologic Oncology
Volume138
Issue number2
DOIs
StatePublished - Aug 1 2015

Fingerprint

Ovarian Neoplasms
Cell Line
Growth
Neoplasms
Nude Mice
Ascites
Heterografts
Research
Histology
Immunohistochemistry
Staining and Labeling
Pharmaceutical Preparations

Keywords

  • High grade serous ovarian cancer
  • Mouse model
  • Pax8
  • Xenograft

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Mitra, A., Davis, D. A., Tomar, S., Roy, L., Gurler, H., Xie, J., ... Burdette, J. E. (2015). In vivo tumor growth of high-grade serous ovarian cancer cell lines. Gynecologic Oncology, 138(2), 372-377. https://doi.org/10.1016/j.ygyno.2015.05.040

In vivo tumor growth of high-grade serous ovarian cancer cell lines. / Mitra, Anirban; Davis, David A.; Tomar, Sunil; Roy, Lynn; Gurler, Hilal; Xie, Jia; Lantvit, Daniel D.; Cardenas, Horacio; Fang, Fang; Liu, Yueying; Loughran, Elizabeth; Yang, Jing; Sharon Stack, M.; Emerson, Robert; Cowden Dahl, Karen; Barbolina, Maria V.; Nephew, Kenneth; Matei, Daniela; Burdette, Joanna E.

In: Gynecologic Oncology, Vol. 138, No. 2, 01.08.2015, p. 372-377.

Research output: Contribution to journalArticle

Mitra, A, Davis, DA, Tomar, S, Roy, L, Gurler, H, Xie, J, Lantvit, DD, Cardenas, H, Fang, F, Liu, Y, Loughran, E, Yang, J, Sharon Stack, M, Emerson, R, Cowden Dahl, K, Barbolina, MV, Nephew, K, Matei, D & Burdette, JE 2015, 'In vivo tumor growth of high-grade serous ovarian cancer cell lines', Gynecologic Oncology, vol. 138, no. 2, pp. 372-377. https://doi.org/10.1016/j.ygyno.2015.05.040
Mitra, Anirban ; Davis, David A. ; Tomar, Sunil ; Roy, Lynn ; Gurler, Hilal ; Xie, Jia ; Lantvit, Daniel D. ; Cardenas, Horacio ; Fang, Fang ; Liu, Yueying ; Loughran, Elizabeth ; Yang, Jing ; Sharon Stack, M. ; Emerson, Robert ; Cowden Dahl, Karen ; Barbolina, Maria V. ; Nephew, Kenneth ; Matei, Daniela ; Burdette, Joanna E. / In vivo tumor growth of high-grade serous ovarian cancer cell lines. In: Gynecologic Oncology. 2015 ; Vol. 138, No. 2. pp. 372-377.
@article{fe764894f19442a49bf5b471ade77981,
title = "In vivo tumor growth of high-grade serous ovarian cancer cell lines",
abstract = "Objective Genomic studies of ovarian cancer (OC) cell lines frequently used in research revealed that these cells do not fully represent high-grade serous ovarian cancer (HGSOC), the most common OC histologic type. However, OC lines that appear to genomically resemble HGSOC have not been extensively used and their growth characteristics in murine xenografts are essentially unknown. Methods To better understand growth patterns and characteristics of HGSOC cell lines in vivo, CAOV3, COV362, KURAMOCHI, NIH-OVCAR3, OVCAR4, OVCAR5, OVCAR8, OVSAHO, OVKATE, SNU119 and UWB1.289 cells were assessed for tumor formation in nude mice. Cells were injected intraperitoneally (i.p.) or subcutaneously (s.c.) in female athymic nude mice and allowed to grow (maximum of 90 days) and tumor formation was analyzed. All tumors were sectioned and assessed using H&E staining and immunohistochemistry for p53, PAX8 and WT1 expression. Results Six lines (OVCAR3, OVCAR4, OVCAR5, OVCAR8, CAOV3, and OVSAHO) formed i.p xenografts with HGSOC histology. OVKATE and COV362 formed s.c. tumors only. Rapid tumor formation was observed for OVCAR3, OVCAR5 and OVCAR8, but only OVCAR8 reliably formed ascites. Tumors derived from OVCAR3, OVCAR4, and OVKATE displayed papillary features. Of the 11 lines examined, three (Kuramochi, SNU119 and UWB1.289) were non-tumorigenic. Conclusions Our findings help further define which HGSOC cell models reliably generate tumors and/or ascites, critical information for preclinical drug development, validating in vitro findings, imaging and prevention studies by the OC research community.",
keywords = "High grade serous ovarian cancer, Mouse model, Pax8, Xenograft",
author = "Anirban Mitra and Davis, {David A.} and Sunil Tomar and Lynn Roy and Hilal Gurler and Jia Xie and Lantvit, {Daniel D.} and Horacio Cardenas and Fang Fang and Yueying Liu and Elizabeth Loughran and Jing Yang and {Sharon Stack}, M. and Robert Emerson and {Cowden Dahl}, Karen and Barbolina, {Maria V.} and Kenneth Nephew and Daniela Matei and Burdette, {Joanna E.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1016/j.ygyno.2015.05.040",
language = "English",
volume = "138",
pages = "372--377",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - In vivo tumor growth of high-grade serous ovarian cancer cell lines

AU - Mitra, Anirban

AU - Davis, David A.

AU - Tomar, Sunil

AU - Roy, Lynn

AU - Gurler, Hilal

AU - Xie, Jia

AU - Lantvit, Daniel D.

AU - Cardenas, Horacio

AU - Fang, Fang

AU - Liu, Yueying

AU - Loughran, Elizabeth

AU - Yang, Jing

AU - Sharon Stack, M.

AU - Emerson, Robert

AU - Cowden Dahl, Karen

AU - Barbolina, Maria V.

AU - Nephew, Kenneth

AU - Matei, Daniela

AU - Burdette, Joanna E.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective Genomic studies of ovarian cancer (OC) cell lines frequently used in research revealed that these cells do not fully represent high-grade serous ovarian cancer (HGSOC), the most common OC histologic type. However, OC lines that appear to genomically resemble HGSOC have not been extensively used and their growth characteristics in murine xenografts are essentially unknown. Methods To better understand growth patterns and characteristics of HGSOC cell lines in vivo, CAOV3, COV362, KURAMOCHI, NIH-OVCAR3, OVCAR4, OVCAR5, OVCAR8, OVSAHO, OVKATE, SNU119 and UWB1.289 cells were assessed for tumor formation in nude mice. Cells were injected intraperitoneally (i.p.) or subcutaneously (s.c.) in female athymic nude mice and allowed to grow (maximum of 90 days) and tumor formation was analyzed. All tumors were sectioned and assessed using H&E staining and immunohistochemistry for p53, PAX8 and WT1 expression. Results Six lines (OVCAR3, OVCAR4, OVCAR5, OVCAR8, CAOV3, and OVSAHO) formed i.p xenografts with HGSOC histology. OVKATE and COV362 formed s.c. tumors only. Rapid tumor formation was observed for OVCAR3, OVCAR5 and OVCAR8, but only OVCAR8 reliably formed ascites. Tumors derived from OVCAR3, OVCAR4, and OVKATE displayed papillary features. Of the 11 lines examined, three (Kuramochi, SNU119 and UWB1.289) were non-tumorigenic. Conclusions Our findings help further define which HGSOC cell models reliably generate tumors and/or ascites, critical information for preclinical drug development, validating in vitro findings, imaging and prevention studies by the OC research community.

AB - Objective Genomic studies of ovarian cancer (OC) cell lines frequently used in research revealed that these cells do not fully represent high-grade serous ovarian cancer (HGSOC), the most common OC histologic type. However, OC lines that appear to genomically resemble HGSOC have not been extensively used and their growth characteristics in murine xenografts are essentially unknown. Methods To better understand growth patterns and characteristics of HGSOC cell lines in vivo, CAOV3, COV362, KURAMOCHI, NIH-OVCAR3, OVCAR4, OVCAR5, OVCAR8, OVSAHO, OVKATE, SNU119 and UWB1.289 cells were assessed for tumor formation in nude mice. Cells were injected intraperitoneally (i.p.) or subcutaneously (s.c.) in female athymic nude mice and allowed to grow (maximum of 90 days) and tumor formation was analyzed. All tumors were sectioned and assessed using H&E staining and immunohistochemistry for p53, PAX8 and WT1 expression. Results Six lines (OVCAR3, OVCAR4, OVCAR5, OVCAR8, CAOV3, and OVSAHO) formed i.p xenografts with HGSOC histology. OVKATE and COV362 formed s.c. tumors only. Rapid tumor formation was observed for OVCAR3, OVCAR5 and OVCAR8, but only OVCAR8 reliably formed ascites. Tumors derived from OVCAR3, OVCAR4, and OVKATE displayed papillary features. Of the 11 lines examined, three (Kuramochi, SNU119 and UWB1.289) were non-tumorigenic. Conclusions Our findings help further define which HGSOC cell models reliably generate tumors and/or ascites, critical information for preclinical drug development, validating in vitro findings, imaging and prevention studies by the OC research community.

KW - High grade serous ovarian cancer

KW - Mouse model

KW - Pax8

KW - Xenograft

UR - http://www.scopus.com/inward/record.url?scp=84938208205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938208205&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2015.05.040

DO - 10.1016/j.ygyno.2015.05.040

M3 - Article

C2 - 26050922

AN - SCOPUS:84938208205

VL - 138

SP - 372

EP - 377

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -